Somerville, MA, United States of America

Allan Capili

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 14.4

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Allan Capili in TGFβ1 Inhibition

Introduction

Allan Capili is a notable inventor based in Somerville, MA. He has garnered recognition in the field of biomedicine with his innovative contributions focusing on selective inhibition of TGFβ1 and TGFβ2 proteins. With two patents to his name, he has played a significant role in advancing therapeutic solutions.

Latest Patents

Allan Capili's latest patents include groundbreaking work involving isoform-selective TGFβ1 inhibitors. One of his patents discloses monoclonal antibodies and antigen-binding fragments capable of selectively inhibiting TGFβ1 with high potency. Along with this, the related compositions, methods, and therapeutic uses related to these inhibitors are also highlighted. His other patent presents similar innovations focused on isoform-selective inhibition of TGFβ2, enhancing the understanding and potential treatments surrounding these critical proteins.

Career Highlights

Currently, Allan Capili is associated with Scholar Rock, Inc., where he leverages his expertise to drive innovations in the pharmaceutical field. His work aims to refine treatments for various conditions related to TGFβ1 and TGFβ2, which are essential in numerous biological processes.

Collaborations

Throughout his career, Allan has collaborated with several esteemed professionals, including Abhishek Datta and Thomas Schurpf. Their collective efforts have facilitated advancements in their research endeavors, aiming for impactful results in the healthcare sector.

Conclusion

Allan Capili's contributions to the field of biomedicine through his patents on TGFβ inhibitors showcase his commitment to innovation and research. His work at Scholar Rock, Inc., alongside talented colleagues, underscores the importance of collaborative efforts in developing novel therapeutic solutions. The ongoing pursuit of innovation in his field promises to yield significant benefits for future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…